Home › Funds › STEMPOINT CAPITAL LP › ZURA

STEMPOINT CAPITAL LP position in ZURA

ZURA BIO · Health Care

STEMPOINT CAPITAL LP reported holding 1,368,215 shares of ZURA (ZURA BIO) in its Q2 2026 13F filing — a position valued at US$8.1M, representing 1.79% of its reported portfolio and ranking #20 among its reported holdings. STEMPOINT CAPITAL LP has disclosed ZURA holdings in 3 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)1.37M sh
Reported value held$8.07M
Portfolio Weight1.79%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How STEMPOINT CAPITAL LP's ZURA position evolved

STEMPOINT CAPITAL LP first disclosed a stake in ZURA in Q3 2024 at 1,044,168 shares (US$4.2M). The position peaked in Q2 2026 at 1,368,215 shares, worth US$8.1M. Across 3 filings, STEMPOINT CAPITAL LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,368,215 shares valued at US$8.1M — an increase of 614,695 shares quarter over quarter.. Notable position changes include a 82% increase in Q2 2026 (shares fell 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.04M $4.24M New
Q1 2026 753.52K $4.48M New
Q2 2026 1.37M $8.07M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZURA and 13F data

ZURA (ZURA BIO) is a Health Care company. 52 other funds we track also report a position in ZURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$55.7M), Venrock Adviser, LLC (US$38.0M), MPM BioImpact LLC (US$26.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZURA

All ZURA fund holders →

FAQ

How long has STEMPOINT CAPITAL LP held ZURA?

STEMPOINT CAPITAL LP has disclosed ZURA holdings in 3 of the last 8 reported quarters, going back to Q3 2024.

What is STEMPOINT CAPITAL LP's current position in ZURA?

As of Q2 2026, STEMPOINT CAPITAL LP holds 1.37M shares of ZURA (ZURA BIO), valued at $8.07M, representing 1.79% of its reported portfolio and ranking #20.

Has STEMPOINT CAPITAL LP been buying or selling ZURA?

In the latest 13F filing (Q2 2026), STEMPOINT CAPITAL LP increased its position in ZURA. The position peaked in Q2 2026 at 1.37M shares.

Which other funds hold ZURA?

Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, MPM BioImpact LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.